tiprankstipranks
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market

Mankind Pharma Ltd. (MANKIND) Ratios

13 Followers

Mankind Pharma Ltd. Ratios

IN:MANKIND's free cash flow for Q2 2026 was ₹0.43. For the 2026 fiscal year, IN:MANKIND's free cash flow was decreased by ₹ and operating cash flow was ₹0.21. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.14 1.23 3.10 2.32 1.68
Quick Ratio
0.87 0.86 2.37 1.52 1.01
Cash Ratio
0.08 0.10 0.18 0.16 0.12
Solvency Ratio
0.20 0.20 0.97 0.78 0.57
Operating Cash Flow Ratio
0.23 0.43 1.02 0.96 0.35
Short-Term Operating Cash Flow Coverage
0.39 0.82 12.58 12.79 1.12
Net Current Asset Value
₹ -51.72B₹ -62.03B₹ 41.81B₹ 22.61B₹ 15.75B
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.31 0.02 0.02 0.10
Debt-to-Equity Ratio
0.55 0.59 0.02 0.02 0.14
Debt-to-Capital Ratio
0.35 0.37 0.02 0.02 0.12
Long-Term Debt-to-Capital Ratio
0.21 0.28 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.88 1.94 1.28 1.31 1.49
Debt Service Coverage Ratio
0.70 0.91 11.82 9.18 1.94
Interest Coverage Ratio
3.76 6.17 146.90 38.53 92.00
Debt to Market Cap
0.10 0.09 <0.01 <0.01 0.02
Interest Debt Per Share
219.39 220.41 5.87 5.30 22.30
Net Debt to EBITDA
2.08 2.24 -0.06 -0.07 0.27
Profitability Margins
Gross Profit Margin
63.25%70.76%67.87%38.76%68.26%
EBIT Margin
20.61%24.06%23.33%19.45%25.45%
EBITDA Margin
27.07%29.15%27.18%23.18%27.59%
Operating Profit Margin
18.67%20.61%39.54%18.51%23.92%
Pretax Profit Margin
15.72%20.61%23.22%19.12%25.38%
Net Profit Margin
12.85%16.31%18.51%14.66%18.42%
Continuous Operations Profit Margin
13.00%16.44%18.79%14.98%18.67%
Net Income Per EBT
81.79%79.12%79.73%76.70%72.60%
EBT Per EBIT
84.18%100.02%58.71%103.29%106.09%
Return on Assets (ROA)
6.18%7.17%15.99%13.19%15.67%
Return on Equity (ROE)
12.95%13.89%20.43%17.24%23.29%
Return on Capital Employed (ROCE)
11.90%11.39%41.52%20.61%28.53%
Return on Invested Capital (ROIC)
8.26%8.00%33.01%15.86%18.65%
Return on Tangible Assets
14.26%17.87%18.61%16.15%19.76%
Earnings Yield
2.11%2.00%2.07%2.25%2.52%
Efficiency Ratios
Receivables Turnover
7.27 7.94 12.18 14.43 18.24
Payables Turnover
3.91 3.15 3.01 6.89 2.27
Inventory Turnover
2.58 1.70 2.14 3.57 1.40
Fixed Asset Turnover
4.17 3.75 3.29 2.84 3.26
Asset Turnover
0.48 0.44 0.86 0.90 0.85
Working Capital Turnover Ratio
27.29 4.23 2.99 4.12 3.59
Cash Conversion Cycle
98.31 144.20 79.47 74.47 119.51
Days of Sales Outstanding
50.21 46.00 29.96 25.29 20.02
Days of Inventory Outstanding
141.47 214.11 170.75 102.15 260.12
Days of Payables Outstanding
93.37 115.91 121.24 52.97 160.62
Operating Cycle
191.68 260.11 200.71 127.44 280.13
Cash Flow Ratios
Operating Cash Flow Per Share
39.65 59.64 53.73 44.55 22.96
Free Cash Flow Per Share
33.08 48.25 44.19 23.78 -35.59
CapEx Per Share
6.57 11.39 9.54 20.77 58.55
Free Cash Flow to Operating Cash Flow
0.83 0.81 0.82 0.53 -1.55
Dividend Paid and CapEx Coverage Ratio
5.24 5.24 5.63 2.14 0.39
Capital Expenditure Coverage Ratio
6.04 5.24 5.63 2.14 0.39
Operating Cash Flow Coverage Ratio
0.20 0.28 10.39 10.47 1.05
Operating Cash Flow to Sales Ratio
0.12 0.20 0.21 0.20 0.12
Free Cash Flow Yield
1.62%1.96%1.91%1.67%-2.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
47.33 49.96 48.41 44.45 39.75
Price-to-Sales (P/S) Ratio
6.08 8.15 8.96 6.52 7.32
Price-to-Book (P/B) Ratio
5.51 6.94 9.89 7.66 9.26
Price-to-Free Cash Flow (P/FCF) Ratio
61.68 50.94 52.32 59.82 -39.96
Price-to-Operating Cash Flow Ratio
51.45 41.22 43.03 31.93 61.95
Price-to-Earnings Growth (PEG) Ratio
44.98 16.80 0.98 -4.21 3.00
Price-to-Fair Value
5.51 6.94 9.89 7.66 9.26
Enterprise Value Multiple
24.56 30.19 32.90 28.05 26.80
Enterprise Value
921.05B 1.07T 924.37B 568.41B 575.46B
EV to EBITDA
24.58 30.19 32.90 28.05 26.80
EV to Sales
6.65 8.80 8.94 6.50 7.40
EV to Free Cash Flow
67.45 55.02 52.22 59.67 -40.36
EV to Operating Cash Flow
56.27 44.51 42.95 31.85 62.57
Tangible Book Value Per Share
-19.59 -50.61 197.03 146.54 110.38
Shareholders’ Equity Per Share
370.30 354.18 233.73 185.61 153.65
Tax and Other Ratios
Effective Tax Rate
0.17 0.20 0.19 0.22 0.26
Revenue Per Share
335.32 301.67 257.99 218.25 194.25
Net Income Per Share
43.10 49.20 47.75 32.00 35.78
Tax Burden
0.82 0.79 0.80 0.77 0.73
Interest Burden
0.76 0.86 1.00 0.98 1.00
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.23 0.28 0.22 0.13 0.02
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 0.00
Income Quality
0.75 1.21 1.13 1.39 0.47
Currency in INR